Check Rucaparib Cost, Availability & Supplier | IKRIS Pharma
-
Designated as a PARP inhibitor, Rucaparib is used as an anti-cancer agent. It is a first-in-class pharmaceutical drug that targets the DNA repair enzyme poly-ADP ribose polymerase-1. It is approved as a third line treatment in BRCA-mutated ovarian cancer. The rucaparib cost is less and reasonable. Rucaparib, in conjunction with other anti-cancer medicines, is also used to treat patients with prostate cancer. This medication is available in the form of a tablet for oral administration.
